Effect of Adjuvant Imiquimod 5% Cream on Sustained Clearance of Anogenital Warts Following Laser Treatment
| Author(s) : | Hopfenmüller W. Schneede P. Schindler A.-E. Hagedorn M. Hoyme U. B. Schorn K. Eul A. , |
| Publisher : | N/A |
| Publication Date : | 2002 |
| ISSN : | N/A |
| Abstract : | Objectives: Imiquimod is an immune response modifier that has demonstrated a good efficacy and relatively low recurrencerates in comparison to other genitalwart treatment modalities. The primary objective of this open-label study was to evaluate the effect on sustained clearance of treated lesions and the safety of patient-applied topical imiquimod after laser therapy of external anogenital warts., |